Same industry

ABUS against four drug peers, a year at 100

80100120140160Feb ’26MayAugNov ’26LLY+30.5%JNJ+33.7%ABBV+21.0%MRK+40.9%ABUS−4.6%

ABUS −4.6%. Merck +40.9%, Johnson & Johnson +33.7%, Eli Lilly +30.5%, AbbVie +21.0%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ABUS’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

ABUS: stories, the record and filings →